Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pank, Lynn"'
Autor:
Abbiss, Hayley, Abbott, Simon, Armstrong, Miranda, Balkwill, Angela, Benson, Vicky, Beral, Valerie, Black, Judith, Bradbury, Kathryn, Brown, Anna, Buron, Andrea, Cairns, Benjamin, Canoy, Dexter, Chadwick, Andrew, Crossley, Barbara, Crowe, Francesca, Ewart, Dave, Ewart, Sarah, Fletcher, Lee, Floud, Sarah, Gathani, Toral, Gerrard, Laura, Goodill, Adrian, Green, Jane, Guiver, Lynden, Hozak, Michal, Kan, Sau Wan, Key, Tim, Kirichek, Oksana, Kroll, Mary, Langston, Nicky, Lingard, Isobel, Luque, Maria Jose, Moser, Kath, Pank, Lynn, Pirie, Kirstin, Reeves, Gillian, Shaw, Keith, Sherman, Emma, Sherry-Starmer, Evie, Schmidt, Julie, Strange, Helena, Sweetland, Sian, Timadjer, Alison, Tipper, Sarah, Travis, Ruth, Trickett, Lyndsey, Wright, Lucy, Yang, Owen, Young, Heather, Yang, T.O. *, Reeves, G.K., Green, J., Beral, V., Cairns, B.J.
Publikováno v:
In Annals of Oncology September 2014 25(9):1836-1843
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Howard, Robert, Zubko, Olga, Bradley, Rosie, Harper, Emma, Pank, Lynn, O'Brien, John, Fox, Chris, Tabet, Naji, Livingston, Gill, Bentham, Peter, McShane, Rupert, Burns, Alistair, Richie, Craig, Reeves, Suzzane, Lovestone, Simon, Ballard, Clive, Noble, Wendy, Nilforooshan, Ramin, Wilcock, Gordon, Gray, Richard
Importance - There are no disease-modifying treatments for Alzheimer disease (AD), the most common cause of dementia. Minocycline is anti-inflammatory, protects against the toxic effects of β-amyloid in vitro and in animal models of AD, and is a cre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::e3c3e5daa514720dde463750701480dc
http://sro.sussex.ac.uk/id/eprint/88421/4/__smbhome.uscs.susx.ac.uk_tjk30_Documents_jamaneurology_howard_2019_oi_190089.pdf
http://sro.sussex.ac.uk/id/eprint/88421/4/__smbhome.uscs.susx.ac.uk_tjk30_Documents_jamaneurology_howard_2019_oi_190089.pdf
Autor:
Howard, Robert J., Zubko, Olga, Bradley, Rosie, Harper, Emma, Kelly, Linda, Pank, Lynn, O'Brien, John T, Fox, Chris, Tabet, Naji, Livingstone, Gill, Bentham, Peter, McShane, Rupert, Burns, Alistair, Ritchie, Craig, Reeves, Suzanne, Lovestone, Simon, Ballard, Clive, Noble, Wendy Jane, Nilforooshan, Ramin, Wilcock, Gordon, Gray, Richard John
Publikováno v:
Howard, R J, Zubko, O, Bradley, R, Harper, E, Kelly, L, Pank, L, O'Brien, J T, Fox, C, Tabet, N, Livingstone, G, Bentham, P, McShane, R, Burns, A, Ritchie, C, Reeves, S, Lovestone, S, Ballard, C, Noble, W J, Nilforooshan, R, Wilcock, G & Gray, R J 2019, ' Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease : A randomized clinical trial ', JAMA Neurology . https://doi.org/10.1001/jamaneurol.2019.3762
Howard, R, Zubko, O, Bradley, R, Harper, E, Pank, L, O’brien, J, Fox, C, Tabet, N, Livingston, G, Bentham, P, Mcshane, R, Burns, A, Ritchie, C, Reeves, S, Lovestone, S, Ballard, C, Noble, W, Nilforooshan, R & Wilcock, G & Gray, R 2019, ' Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease : A Randomized Clinical Trial ', JAMA Neurology, vol. 77, no. 2, pp. 164 . https://doi.org/10.1001/jamaneurol.2019.3762
Howard, R, Zubko, O, Bradley, R, Harper, E, Pank, L, O’brien, J, Fox, C, Tabet, N, Livingston, G, Bentham, P, Mcshane, R, Burns, A, Ritchie, C, Reeves, S, Lovestone, S, Ballard, C, Noble, W, Nilforooshan, R & Wilcock, G & Gray, R 2019, ' Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease : A Randomized Clinical Trial ', JAMA Neurology, vol. 77, no. 2, pp. 164 . https://doi.org/10.1001/jamaneurol.2019.3762
Importance There are no disease-modifying treatments for Alzheimer disease (AD), the most common cause of dementia. Minocycline is anti-inflammatory, protects against the toxic effects of β-amyloid in vitro and in animal models of AD, and is a credi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f375ff212c178da50823cea5cefd5471
https://kclpure.kcl.ac.uk/ws/files/115950872/MADETrialManuscriptTextCleanVersion30August.docx
https://kclpure.kcl.ac.uk/ws/files/115950872/MADETrialManuscriptTextCleanVersion30August.docx
Autor:
Gathercole, Rebecca, Bradley, Rosie, Harper, Emma, Davies, Lucy, Pank, Lynn, Lam, Natalie, Davies, Anna, Talbot, Emma, Hooper, Emma, Winson, Rachel, Scutt, Bethany, Montano, Victoria Ordonez, Nunn, Samantha, Lavelle, Grace, Lariviere, Matthew, Hirani, Shashivadan, Brini, Stefano, Bateman, Andrew, Bentham, Peter, Burns, Alistair
Publikováno v:
Health Technology Assessment; Mar2021, Vol. 25 Issue 19, pvii-156, 161p
Autor:
Davies A; School of Health Sciences City University of London London UK., Brini S; School of Health Sciences City University of London London UK., Hirani S; School of Health Sciences City University of London London UK., Gathercole R; Department of Old Age Psychiatry Institute of Psychiatry London UK., Forsyth K; School of Health Sciences Queen Margaret University Edinburgh UK., Henderson C; South London and Maudsley NHS Foundation Trust London UK., Bradley R; Clinical Trial Service Unit Oxford UK., Davies L; Clinical Trial Service Unit Oxford UK., Dunk B; South London and Maudsley NHS Foundation Trust London UK., Harper E; Clinical Trial Service Unit Oxford UK., Lam N; Clinical Trial Service Unit Oxford UK., Pank L; Medical Research Council Population Health Research Unit Oxford University Oxford UK., Leroi I; Global Brain Health Institute Trinity College Dublin Dublin 2 Ireland., Woolham J; Social Care Workforce Research Unit King's College London London UK., Fox C; School of Medicine Health Policy and Practice University of East Anglia Norwich Norfolk UK., O'Brien J; Department of Psychiatry University of Cambridge Cambridge UK., Bateman A; Oliver Zangwill Centre for Neuropsychological Rehabilitation Princess of Wales Hospital Ely UK., Poland F; School of Allied Health Professionals University of East Anglia Norwich Norfolk UK., Bentham P; The Barberry Centre Birmingham UK., Burns A; Global Brain Health Institute Trinity College Dublin Dublin 2 Ireland., Gray R; Clinical Trial Service Unit Oxford UK., Knapp M; Department of Old Age Psychiatry Institute of Psychiatry London UK., Talbot E; Norfolk and Suffolk NHS Foundation Trust Suffolk UK., Hooper E; Lancashire Care NHS Foundation Trust Preston UK., Winson R; Cambridgeshire Community Services NHS Trust Oliver Zangwill Centre Ely UK., Scutt B; Department of Old Age Psychiatry Institute of Psychiatry London UK., Ordonez V; Cambridgeshire Community Services NHS Trust Oliver Zangwill Centre Ely UK., Nunn S; Cambridgeshire Community Services NHS Trust Oliver Zangwill Centre Ely UK., Lavelle G; Department of Old Age Psychiatry Institute of Psychiatry London UK., Howard R; Division of Psychiatry University College London London UK.; Policy and Evaluation Centre London School of Economics and Political Science London UK.; Oxford Health NHS Foundation Trust Warneford Hospital Headington Oxford UK.; Centre for Clinical Brain Sciences University of Edinburgh Edinburgh UK., Newman S; School of Health Sciences City University of London London UK.
Publikováno v:
Alzheimer's & dementia (New York, N. Y.) [Alzheimers Dement (N Y)] 2020 Oct 07; Vol. 6 (1), pp. e12064. Date of Electronic Publication: 2020 Oct 07 (Print Publication: 2020).
Autor:
Howard R; Division of Psychiatry, University College London, London, UK, Zubko O; Department of Old Age Psychiatry, King’s College London, London, UK, Gray R; Nuffield Department of Population Health, University of Oxford, Oxford, UK, Bradley R; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK, Harper E; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK, Kelly L; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK, Pank L; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, UK, O’Brien J; Department of Psychiatry, University of Cambridge, Cambridge, UK, Fox C; Norwich Medical School, University of East Anglia, Norwich, UK, Tabet N; Department of Old Age Psychiatry, University of Sussex, Brighton, UK, Livingston G; Division of Psychiatry, University College London, London, UK, Bentham P; The Barberry Centre, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham, UK, McShane R; Department of Psychiatry, University of Oxford, Oxford, UK, Burns A; Department of Old Age Psychiatry, University of Manchester, Manchester, UK, Ritchie C; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK, Reeves S; Division of Psychiatry, University College London, London, UK, Lovestone S; Department of Psychiatry, University of Oxford, Oxford, UK, Ballard C; Medical School, University of Exeter, Exeter, UK, Noble W; Department of Basic and Clinical Neuroscience, King’s College London, London, UK, Wilcock G; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK, Nilforooshan R; Abraham Cowley Unit, Surrey and Borders Partnership NHS Foundation Trust, Redhill, UK
Publikováno v:
2020 Apr.
Autor:
Howard R; Division of Psychiatry, University College London, London, United Kingdom., Zubko O; Old Age Psychiatry, King's College London, London, United Kingdom., Bradley R; Medical Research Council Population Health Research Unit, University of Oxford, Oxford, United Kingdom., Harper E; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., Pank L; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom., O'Brien J; Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom., Fox C; Norwich Medical School, University of East Anglia, Norwich, United Kingdom., Tabet N; Department of Old Age Psychiatry, University of Sussex, Brighton, United Kingdom., Livingston G; Division of Psychiatry, University College London, London, United Kingdom., Bentham P; Birmingham and Solihull Mental Health National Health Service Foundation Trust, Birmingham, United Kingdom., McShane R; Department of Psychiatry, University of Oxford, Oxford, United Kingdom., Burns A; Department of Old Age Psychiatry, University of Manchester, Manchester, United Kingdom., Ritchie C; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom., Reeves S; Division of Psychiatry, University College London, London, United Kingdom., Lovestone S; Department of Psychiatry, University of Oxford, Oxford, United Kingdom., Ballard C; Medical School, University of Exeter, Exeter, United Kingdom., Noble W; Department of Basic and Clinical Neuroscience, King's College London, London, United Kingdom., Nilforooshan R; Surrey and Borders Partnership National Health Service Foundation Trust, United Kingdom., Wilcock G; Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Gray R; Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Publikováno v:
JAMA neurology [JAMA Neurol] 2020 Feb 01; Vol. 77 (2), pp. 164-174.